Updates

August 18, 2026 The Manager The Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Hirose Jeejebhoy Towers “Exchange Plaza” Dalal Street Bandra-Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai — 400051 Scrip Code (BSE): 544009 Symbol: BLUEJET Sub.: Business Responsibility and Sustainability Report of Blue Jet Healthcare Limited (“the Company”) Dear Sir/ Ma’am, Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Business Responsibility and Sustainability Report of the Company (‘BRSR’) for the financial year 2025-26. BRSR for the financial year 2025-26 is also available on the Company’s website at www.bluejethealthcare.com We request you to take the same on your records. Thanking You, For BLUE JET HEALTHCARE LIMITED Sweta Poddar Company Secretary & Compliance Officer (M. No: F12287) Encl.: as above STATUTORY REPORTS Business Responsibility & Sustainability Report (BRSR) SECTION A: GENERAL DISCLOSURES I. DETAILS OF THE LISTED ENTITY 1. Corporate Identity Number (CIN) of the Listed Entity L99999MH1968PLC014154 2. Name of the Listed Entity Blue Jet Healthcare Limited 3. Year of incorporation 1968 as Jet Chemicals Private Limited 4. Registered office address Office no. 701,702, 7th Floor, Bhumiraj Costarica, Sector 18, Sanpada, Navi Mumbai, Thane 400705, Maharashtra, India. 5. Corporate address Office no. 701,702, 7th Floor, Bhumiraj Costarica, Sector 18, Sanpada, Navi Mumbai, Thane 400705, Maharashtra, India. 6. E-mail companysecretary@bluejethealthcare.com 7. Telephone +91-022- 69891200 8. Website https://bluejethealthcare.com/ 9. Financial year for which reporting is being done Financial Year 2025-26 10. Name of the Stock Exchange(s) where shares are • BSE Limited (BSE) listed • National Stock Exchange Limited (NSE) 11. Paid-up Capital Rs. 346,930,850 12. Name and contact details (telephone, email Ms. Sweta Poddar (Company Secretary & address) of the person who may be contacted in Compliance Officer) case of any queries on the BRSR report T: + 91-022- 69891200 E: Companysecretary@bluejethealthcare.com 13. Reporting boundary Disclosures made in this report are on standalone basis and pertain only to “Blue Jet Are the disclosures under this report made on a Healthcare Limited”, unless otherwise stated. standalone basis (i.e., only for the entity) or on a consolidated basis (i.e., for the entity and all the entities which form a part of its consolidated financial statements, taken together). 14. Name of assessment or assurance provider TUV India Pvt Ltd 15. Type of assessment or assurance obtained Reasonable Assurance for BRSR Core Indicators II. PRODUCTS/SERVICES 16. Details of business activities (accounting for 90% of the turnover): SL. Description of Main Activity Description of Business Activity % Of Turnover of the No. Entity (FY25-26) 1. Manufacturing Chemical and chemical products, 100% pharmaceuticals, medicinal chemical, and botanical products Blue Jet Healthcare Ltd. | Annual Report 2025-26 17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover) S. Product/Service NIC Code % Of Total Turnover No. Contributed 1. Contrast Media 20116 53% 2. High Intensity Sweeteners 20299 14% 3. Pharmaceutical intermediaries and Active 21002 33% Pharmaceuticals Ingredients and other III. OPERATIONS 18. Number of locations where plants and/or operations/offices of the entity are situated: Location Number of operational locations Number of offices Total National 8 1 9 International 0 0 0 19. Markets served by the entity: a. Number of locations Locations Number National (No. of States) 7 International (No. of Countries) 50+ (Including Norway, USA, Denmark, Switzerland, France, Spain, Italy, Sweden, Thailand) b. What is the contribution of exports as a percentage of the total turnover of the entity? The contribution of exports as a percentage to total turnover is about 90%. c. A brief on types of customers Blue Jet Healthcare Limited serves a diverse range of customers within the pharmaceutical and FMCG industries. As a B2B (business-to-business) Company specialises in manufacturing Integrated Contrast Media, Saccharin and its salts, as well as Niche Pharmaceutical intermediaries and Active Pharmaceutical Ingredients (APIs), the Company’s primary customers include innovator pharmaceutical companies, research laboratories, multinational generic pharmaceuticals companies, agrochemical companies and FMCGs. IV. EMPLOYEES 20. Details at the end of Financial Year: a. Employees and workers (including differently abled): S. Particulars Total (A) Male Female No. No. (B) % (B / A) No. (C) % (C / A) Employees 1. Permanent (D) 197 167 84.77% 30 15.23% 2. Other than Permanent (E) 311 271 87.14% 40 12.86% 3. Total employees (D + E) 508 438 86.22% 70 13.78% Workers 4. Permanent (F) 37 37 100.00% 0 0.00% 5. Other than Permanent (G) 36 36 100.00% 0 0.00% 6. Total Workers (F + G) 73 73 100.00% 0 0.00% STATUTORY REPORTS b. Differently abled Employees: S. Particulars Total (A) Male Female No. (B) % (B / A) No. (C) % (C / A) Differently abled Employees 1. Permanent (D) The Company has not employed any differently abled 2. Other than Permanent (E) employees. However, the Company is fully committed to providing equal opportunities to all individuals 3. Total employees (D + E) Differently abled Workers 4. Permanent (F) The Company has not employed any differently abled 5. Other than Permanent (G) employees. However, the Company is fully committed to providing equal opportunities to all individuals 6. Total employees (F + G) 21. Participation/Inclusion/Representation of women Category Total No. and percentage of Females No. (B) % (B / A) Board of Directors 8 3 37.5% Key Management Personnel (KMP) 2 1 50.00% Note: KMP mentioned do not include directors 22. Turnover rate for permanent employees and workers Category FY25-26 FY24-25 FY23-24 Male Female Total Male Female Total Male Female Total Permanent Employees 8.33% 14.86% 7.07% 11.57% 9.09% 11.19% 11.22% 5.26% 10.26% Permanent Workers 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.41% 0.00% 7.41% V. HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES (INCLUDING JOINT VENTURES) 23. (a) Names of holding / subsidiary / associate companies / joint ventures S. Name of the holding / Indicate whether % of shares Does the entity indicated No. subsidiary / associate holding/ held by listed at column A, participate in companies / joint Subsidiary/ enti5ty the Business Responsibility ventures (A) Associate/ Joint initiatives of the listed Venture entity? (Yes/No) Bluejet has no holding or subsidiary companies VI. CSR DETAILS 24. (i) Whether CSR is applicable as per section 135 of Companies Act, 2013: (Yes/No) – Yes (ii) Turnover ( In million) - 9,473.21/- (iii) Net worth ( In million) – 13,599.12/- Blue Jet Healthcare Ltd. | Annual Report 2025-26 VII. TRANSPARENCY AND DISCLOSURES COMPLIANCES 25. Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible Business Conduct: Stakeholder Grievance FY25-26 FY24-25 group from Redressal Number of Number of Remarks Number of Number of Remarks whom Mechanism complaints complaints complaints complaints complaint is in place filed during pending filed during pending received (Yes/No) the year resolution at the year resolution at close of the close of the year year Investors Yes 0 0 - 0 0 - (other than shareholders) Shareholders Yes 0 0 - 0 0 - Employees & Yes 0 0 - 0 0 - workers Customers Yes 0 0 - 0 0 - Value Chain Yes 0 0 - 0 0 - Partners Communities Yes 0 0 - 0 0 - 26. Overview of the entity’s material responsible business conduct issues Please indicate material responsible business conduct and sustainability issues pertaining to environmental and social matters that present a risk or an opportunity to your business, rationale for identifying the same, approach t [Showing first 8,000 characters — download PDF for full document]